A simulation that consists of diverse, real-world patients, each with a unique response profile to your investigational therapy that closely approximates actual likely response.
KM analysis of progression-free survival in a multiple myeloma trial for 1L patients
An integrated data framework bridging the biomedical, clinical, and epidemiological domains
350M Lives
Multi Modal Data
100K Drugs
Data Elements
Biomedical
Knowledge Graph
180K Trials
Curated Results Data
Supporting Sponsors from Early Clinical Development to Approval